New experiment show drug-combination can boost checkpoint therapies in deadly cancers
July 12, 2020 12:37 ISTA recent experiment in mice suggested that immune checkpoint therapies can get a boost if combined with other drugs targeting myeloid-derived suppressor cells, or MDSCs. These cells reach unusually high levels in people with cancer. Checkpoint therapies have helped thousands of people with some incurable cancers